Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
Lisa R. Susswein, Wendy K. Chung(Oregon Health & Science University), Lauren Yackowski, Guido D. Pollevick, Scott M. Weissman(Consultants in Neurology), Mattia Cremona, Gabi Richard, Federica Gibellini, Sherri J. Bale(Unknown), Daniel Pineda‐Alvarez, Jeffrey Bissonnette, Kristen J. Vogel Postula, Kathleen S. Hruska, Megan L. Marshall(St Mark's Hospital), Patricia D. Murphy(Newark Beth Israel Medical Center), Zhixiong Xu, Jessica K. Booker, Rachel Nusbaum(Icahn School of Medicine at Mount Sinai), Rachel T. Klein, Erica Vaccari
Cited by 292
Related Papers
Pediatric Pulmonary Hypertension
|Circulation|2015|1.1k
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
|Science|2015|980
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
|PubMed|1989|963
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands
|Nature Genetics|2017|945